Patents by Inventor Jason OLEJNICZAK

Jason OLEJNICZAK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TUBULIN INHIBITORS
    Publication number: 20220089539
    Abstract: Provided herein are compounds, pharmaceutical compositions, and methods of treatment for various diseases, such as cancer. In one aspect, the method comprises the treatment of brain cancers or metastatic cancers that spread to the brain.
    Type: Application
    Filed: April 29, 2021
    Publication date: March 24, 2022
    Inventors: Tom LIN, Cheng-Chi Irene WANG, Jason OLEJNICZAK, Jessica CRISP, Richard TRUONG
  • FATTY ACID ANALOGUES AND METHODS OF USE
    Publication number: 20210221781
    Abstract: Provided herein are compounds, pharmaceutical compositions, and methods of treatment for various diseases or conditions, such as cancer. In one aspect, the method comprises the treatment of metastatic cancers. Compounds and methods provided herein are also used for the treatment of diseases such as inflammatory disease, cardiovascular disease, autoimmune disease, and dry eye syndrome. Further provided herein are dietary supplement formulations and methods for supporting a healthy lifestyle.
    Type: Application
    Filed: May 15, 2019
    Publication date: July 22, 2021
    Inventors: Yu-Hsin Tom LIN, Cheng-Chi Irene WANG, Jason OLEJNICZAK
  • Tubulin inhibitors
    Patent number: 11040945
    Abstract: Provided herein are compounds, pharmaceutical compositions, and methods of treatment for various diseases, such as cancer. In one aspect, the method comprises the treatment of brain cancers or metastatic cancers that spread to the brain.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: June 22, 2021
    Inventors: Tom Lin, Cheng-Chi Irene Wang, Jason Olejniczak, Jessica Crisp, Richard Truong
  • Stimulus-responsive poly(lactic-co-glycolic)-based polymers and nanoparticles formed therefrom
    Patent number: 10370488
    Abstract: PLGA-based polymers include pendant nucleophiles protected with photocleavable protecting groups. Upon deprotection, the polymers degrade rapidly via intramolecular cyclization into small molecules. The polymer may be formulated as a nanoparticle, with an encapsulated payload, which may be an imaging agent, a bioactive agent or a pharmaceutical agent.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: August 6, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Adah Almutairi, Jason Olejniczak, Minnie Chan
  • TUBULIN INHIBITORS
    Publication number: 20190169127
    Abstract: Provided herein are compounds, pharmaceutical compositions, and methods of treatment for various diseases, such as cancer. In one aspect, the method comprises the treatment of brain cancers or metastatic cancers that spread to the brain.
    Type: Application
    Filed: December 5, 2018
    Publication date: June 6, 2019
    Inventors: Tom LIN, Cheng-Chi Irene WANG, Jason OLEJNICZAK, Jessica CRISP, Richard TRUONG
  • STIMULUS-RESPONSIVE POLY(LACTIC-CO-GLYCOLIC)-BASED POLYMERS AND NANOPARTICLES FORMED THEREFROM
    Publication number: 20180079860
    Abstract: PLGA-based polymers include pendant nucleophiles protected with photocleavable protecting groups. Upon deprotection, the polymers degrade rapidly via intramolecular cyclization into small molecules. The polymer may be formulated as a nanoparticle, with an encapsulated payload, which may be an imaging agent, a bioactive agent or a pharmaceutical agent.
    Type: Application
    Filed: April 8, 2016
    Publication date: March 22, 2018
    Inventors: Adah ALMUTAIRI, Jason OLEJNICZAK, Minnie CHAN